Trials / Completed
CompletedNCT01200524
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 133 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD2423 | 20 mg tablet |
| DRUG | AZD2423 | 50 mg tablet |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2010-09-13
- Last updated
- 2014-04-25
- Results posted
- 2013-09-25
Locations
25 sites across 7 countries: Bulgaria, Denmark, France, Poland, Russia, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01200524. Inclusion in this directory is not an endorsement.